{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:56:03Z","timestamp":1790823363762,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Project of Sichuan Provincial Administration of Traditional Chinese Medicine","award":["2023MS637"],"award-info":[{"award-number":["2023MS637"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01817-2","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:36:57Z","timestamp":1747208217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Establishment of a prognostic nomogram and risk stratification system for patients with combined hepatocellular-cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Qiuhan","family":"Heng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"3","key":"1817_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"1817_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68 (6), 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"1817_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"1817_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0039-3402515","volume":"40","author":"M Komuta","year":"2020","unstructured":"Komuta, M. & Yeh, M. M. A review on the update of combined hepatocellular cholangiocarcinoma. Semin Liver Dis. 40 (2), 124\u2013130 (2020).","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"1817_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S1499-3872(14)60275-7","volume":"13","author":"SD Lee","year":"2014","unstructured":"Lee, S. D. et al. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat. Dis. Int. 13 (6), 594\u2013601 (2014).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"1","key":"1817_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000530700","volume":"13","author":"L Ye","year":"2024","unstructured":"Ye, L. et al. Combined Hepatocellular-Cholangiocarcinoma: biology, diagnosis, and management. Liver Cancer. 13 (1), 6\u201328 (2024).","journal-title":"Liver Cancer"},{"issue":"6","key":"1817_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jjco\/hyg056","volume":"33","author":"Y Yano","year":"2003","unstructured":"Yano, Y. et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn. J. Clin. Oncol. 33 (6), 283\u2013287 (2003).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"1817_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1440-1746.1998.tb00542.x","volume":"13","author":"IO Ng","year":"1998","unstructured":"Ng, I. O., Shek, T. W., Nicholls, J. & Ma, L. T. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J. Gastroenterol. Hepatol. 13 (1), 34\u201340 (1998).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1817_CR9","doi-asserted-by":"crossref","unstructured":"Cutolo, C. et al. Combined hepatocellular-cholangiocarcinoma: what the multidisciplinary team should know. Diagnostics (Basel). 12(4): 890. (2022).","DOI":"10.3390\/diagnostics12040890"},{"key":"1817_CR10","doi-asserted-by":"publisher","first-page":"570958","DOI":"10.3389\/fonc.2020.570958","volume":"10","author":"AA Azizi","year":"2020","unstructured":"Azizi, A. A., Hadjinicolaou, A. V., Goncalves, C., Duckworth, A. & Basu, B. Update on the genetics of and systemic therapy options for combined hepatocellular cholangiocarcinoma. Front. Oncol. 10, 570958 (2020).","journal-title":"Front. Oncol."},{"issue":"5","key":"1817_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufr\u00e8re","year":"2021","unstructured":"Beaufr\u00e8re, A., Calderaro, J. & Paradis, V. Combined hepatocellular-cholangiocarcinoma: an update. J. Hepatol. 74 (5), 1212\u20131224 (2021).","journal-title":"J. Hepatol."},{"issue":"41","key":"1817_CR12","doi-asserted-by":"publisher","first-page":"7173","DOI":"10.3748\/wjg.v27.i41.7173","volume":"27","author":"YY Tang","year":"2021","unstructured":"Tang, Y. Y., Zhao, Y. N., Zhang, T., Chen, Z. Y. & Ma, X. L. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World J. Gastroenterol. 27 (41), 7173\u20137189 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"11\u201312","key":"1817_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/17474124.2022.2150610","volume":"16","author":"D Yang","year":"2022","unstructured":"Yang, D. et al. Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study. Expert Rev. Gastroenterol. Hepatol. 16 (11\u201312), 1115\u20131123 (2022).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"1817_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/his.14384","volume":"79","author":"CC Yen","year":"2021","unstructured":"Yen, C. C. et al. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated world health organization classification. Histopathology. 79 (4), 556\u2013572 (2021).","journal-title":"Histopathology"},{"issue":"13","key":"1817_CR15","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1002\/cam4.2495","volume":"8","author":"P Song","year":"2019","unstructured":"Song, P. et al. Patients\u2019 prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection. Cancer Med. 8 (13), 5862\u20135871 (2019).","journal-title":"Cancer Med."},{"key":"1817_CR16","doi-asserted-by":"crossref","unstructured":"Alkanhel, R. et al. Network intrusion detection based on feature selection and hybrid metaheuristic optimization. Mater. \\& Continua. 74(2). (2023).","DOI":"10.32604\/cmc.2023.033273"},{"key":"1817_CR17","doi-asserted-by":"crossref","unstructured":"Myriam, H. et al. Advanced Meta-Heuristic algorithm based on particle swarm and Al-Biruni Earth radius optimization methods for oral Cancer detection. IEEE Access. 11, 23681\u201323700 (2023).","DOI":"10.1109\/ACCESS.2023.3253430"},{"key":"1817_CR18","doi-asserted-by":"crossref","unstructured":"El-kenawy, E. M. et al. Greylag Goose Optimization: Nature-inspired optimization algorithm. Expert Syst. Appl. 238, 122147 (2024).","DOI":"10.1016\/j.eswa.2023.122147"},{"issue":"1","key":"1817_CR19","first-page":"2833","volume":"9","author":"K Sh","year":"2025","unstructured":"Sh., K. & Kumar, M. Predictive analysis of groundwater resources using random forest regression. J. Artif. Intell. Metaheuristics. 9 (1), 2833\u20135597 (2025).","journal-title":"J. Artif. Intell. Metaheuristics"},{"issue":"4","key":"1817_CR20","first-page":"3591","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Nomogram for predicting the survival of patients with malignant melanoma: A population analysis. Oncol. Lett. 18 (4), 3591\u20133598 (2019).","journal-title":"Oncol. Lett."},{"issue":"1","key":"1817_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12885-024-11976-6","volume":"24","author":"C Yuan","year":"2024","unstructured":"Yuan, C., Zou, S., Wang, K. & Hu, Z. Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population. BMC Cancer. 24 (1), 227 (2024).","journal-title":"BMC Cancer"},{"key":"1817_CR22","doi-asserted-by":"publisher","first-page":"1371409","DOI":"10.3389\/fonc.2024.1371409","volume":"14","author":"L Chen","year":"2024","unstructured":"Chen, L. et al. Prognostic nomogram of overall survival for radiation therapy in hepatocellular carcinoma: a population study based on the SEER database and an external cohort. Front. Oncol. 14, 1371409 (2024).","journal-title":"Front. Oncol."},{"issue":"7","key":"1817_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun. (Lond). 40 (7), 301\u2013312 (2020).","journal-title":"Cancer Commun. (Lond)"},{"issue":"6","key":"1817_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.hbpd.2020.07.004","volume":"19","author":"D Schizas","year":"2020","unstructured":"Schizas, D. et al. Combined hepatocellular-cholangiocarcinoma: an update on epidemiology, classification, diagnosis and management. Hepatobiliary Pancreat. Dis. Int. 19 (6), 515\u2013523 (2020).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"2","key":"1817_CR25","doi-asserted-by":"publisher","first-page":"e0192310","DOI":"10.1371\/journal.pone.0192310","volume":"13","author":"HG van den Boorn","year":"2018","unstructured":"van den Boorn, H. G. et al. Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis. PLoS One. 13 (2), e0192310 (2018).","journal-title":"PLoS One"},{"key":"1817_CR26","doi-asserted-by":"publisher","first-page":"41695","DOI":"10.1038\/srep41695","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma. Sci. Rep. 7, 41695 (2017).","journal-title":"Sci. Rep."},{"issue":"4","key":"1817_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/annonc\/mdp398","volume":"21","author":"G Goldzweig","year":"2010","unstructured":"Goldzweig, G. et al. Psychological distress among male patients and male spouses: what do oncologists need to know. Ann. Oncol. 21 (4), 877\u2013883 (2010).","journal-title":"Ann. Oncol."},{"key":"1817_CR28","doi-asserted-by":"publisher","first-page":"977111","DOI":"10.3389\/fonc.2022.977111","volume":"12","author":"G Deng","year":"2022","unstructured":"Deng, G. et al. Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy. Front. Oncol. 12, 977111 (2022).","journal-title":"Front. Oncol."},{"key":"1817_CR29","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2147\/CMAR.S361462","volume":"14","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. The fibrinogen\/albumin ratio index as an independent prognostic biomarker for patients with combined hepatocellular cholangiocarcinoma after surgery. Cancer Manag. Res. 14, 1795\u20131806 (2022).","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"1817_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1148\/radiol.09091076","volume":"255","author":"JH Kim","year":"2010","unstructured":"Kim, J. H. et al. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 255 (1), 270\u2013277 (2010).","journal-title":"Radiology"},{"issue":"7","key":"1817_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/hepr.13507","volume":"50","author":"YI Yamashita","year":"2020","unstructured":"Yamashita, Y. I. et al. Clinicopathological characteristics of combined hepatocellular cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: high rate of early recurrence and its predictors. Hepatol. Res. 50 (7), 863\u2013870 (2020).","journal-title":"Hepatol. Res."},{"issue":"3","key":"1817_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/cam4.4474","volume":"11","author":"Z Yang","year":"2022","unstructured":"Yang, Z. & Shi, G. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study. Cancer Med. 11 (3), 692\u2013704 (2022).","journal-title":"Cancer Med."},{"issue":"1","key":"1817_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000503719","volume":"9","author":"D Gentile","year":"2020","unstructured":"Gentile, D. et al. Surgical treatment of hepatocholangiocarcinoma: A systematic review. Liver Cancer. 9 (1), 15\u201327 (2020).","journal-title":"Liver Cancer"},{"issue":"4","key":"1817_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/jjco\/hyaf029","volume":"55","author":"T Terashima","year":"2025","unstructured":"Terashima, T., Harada, K. & Yamashita, T. Diagnosis, clinical characteristics, and treatment of combined hepatocellular-cholangiocarcinoma. Jpn. J. Clin. Oncol. 55 (4), 327\u2013333 (2025).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"18","key":"1817_CR35","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.3748\/wjg.v22.i18.4459","volume":"22","author":"AQ Wang","year":"2016","unstructured":"Wang, A. Q. et al. Combined hepatocellular cholangiocarcinoma: controversies to be addressed. World J. Gastroenterol. 22 (18), 4459\u20134465 (2016).","journal-title":"World J. Gastroenterol."},{"issue":"13","key":"1817_CR36","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1245\/s10434-015-4774-y","volume":"22","author":"K Fowler","year":"2015","unstructured":"Fowler, K. et al. Biphenotypic primary liver carcinomas: assessing outcomes of hepatic directed therapy. Ann. Surg. Oncol. 22 (13), 4130\u20134137 (2015).","journal-title":"Ann. Surg. Oncol."},{"issue":"9","key":"1817_CR37","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1245\/s10434-012-2328-0","volume":"19","author":"X Yin","year":"2012","unstructured":"Yin, X. et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann. Surg. Oncol. 19 (9), 2869\u20132876 (2012).","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"1817_CR38","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","volume":"259","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin, G. et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann. Surg. 259 (5), 944\u2013952 (2014).","journal-title":"Ann. Surg."},{"issue":"6","key":"1817_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/lt.25737","volume":"26","author":"E De Martin","year":"2020","unstructured":"De Martin, E. et al. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined Hepatocellular-Cholangiocarcinoma in the setting of cirrhosis. Liver Transpl. 26 (6), 785\u2013798 (2020).","journal-title":"Liver Transpl."},{"issue":"4","key":"1817_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2020.11.017","volume":"232","author":"LA Dageforde","year":"2021","unstructured":"Dageforde, L. A. et al. Multi-center analysis of liver transplantation for combined hepatocellular carcinoma-cholangiocarcinoma liver tumors. J. Am. Coll. Surg. 232 (4), 361\u2013371 (2021).","journal-title":"J. Am. Coll. Surg."},{"issue":"3","key":"1817_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.21873\/anticanres.17499","volume":"45","author":"N Tanabe","year":"2025","unstructured":"Tanabe, N. et al. Efficacy of lenvatinib and atezolizumab bevacizumab combination therapy in patients with combined hepatocellular-cholangiocarcinoma. Anticancer Res. 45 (3), 1117\u20131125 (2025).","journal-title":"Anticancer Res."},{"issue":"10","key":"1817_CR42","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.6004\/jnccn.2018.7053","volume":"16","author":"NA Trikalinos","year":"2018","unstructured":"Trikalinos, N. A. et al. Systemic therapy for combined hepatocellular-cholangiocarcinoma: A single-institution experience. J. Natl. Compr. Cancer Netw. 16 (10), 1193\u20131199 (2018).","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01817-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:37:01Z","timestamp":1747208221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01817-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01817-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data were obtained from a publicly accessible database and ethical approvals were not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}],"article-number":"16726"}}